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Background: The UK Equality Act 2010 makes it unlawful for employers to ask health questions before making an
offer of employment except in certain circumstances. While the majority of employers would prefer applicants to
disclose a mental illness at the application stage, many people either wait until they have accepted the job and
then disclose to an occupational health professional, or do not do so at all due to the anticipation of discrimination
or a wish for privacy. However, non disclosure precludes the ability to request reasonable adjustments in the
workplace or to make a claim of direct discrimination. Disclosure to employers is therefore a difficult decision. A
recent pilot study by our group of the CORAL decision aid showed that it helped mental health service users clarify
their needs and values regarding disclosure and led to reduction in decisional conflict. The present proof of
concept trial aims to determine whether a full scale randomised controlled trial (RCT) is justifiable and feasible, and
to optimise its design.
Methods: In this single blind exploratory RCT in London, a total of 80 participants (inclusion criteria: age
≥18 years, on the caseload of a specialist employment adviser working with people with mental illness;
referred to the adviser either from primary care via Improving Access to Psychological Therapies or secondary
mental health service; currently seeking or interested in either paid or voluntary employment, and a
Decisional Conflict Scale score of 37.5 or greater and stage of decision score 1–5) will be recruited from
vocational advice services. After completing a baseline assessment, participants will be randomly assigned to
one of two conditions (1) Use of the CORAL Decision Aid (DA) in addition to treatment as usual or (2)
Treatment as usual. Those allocated to the DA condition will be given it to read and complete, and the
researcher will be present to record the time taken and any content that causes confusion. Intervention
participants may keep the decision aid but are discouraged from showing it to other service users to avoid
contamination. Follow up interviews will be conducted at 3 months. Primary outcomes are: (i) stage of
decision making score; (ii) decisional conflict scores and (iii) employment related outcomes. Secondary
analyses will identify predictors of disclosure and qualitative analysis will explore the impact of the
intervention.
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Discussion: A reduction in decisional conflict regarding disclosure leading to more effective job seeking
activity could have significant economic consequences for people with mental illness in terms of employment
rates and productivity.
Trial registration number: NCT01379014 (ClinicalTrials.gov Identifier)
Keywords: Decision aid, Disclosure of illness, Employment, Single blind, Randomised controlled trialBackground
People with mental health problems frequently report dis-
crimination in employment. In a US survey 61% (n=1,301)
felt they had been turned down for a job for which they are
qualified when they disclosed their illness [1]. In the UK,
56% (n=411) believed that they had definitely or possibly
been turned down for a job in the past because of their
mental health problems [2]. Similarly, in a recent inter-
national survey, 64% of participants (n=736) reported stop-
ping themselves from applying for work, training or
education due to anticipated discrimination as a result of
their diagnosis of schizophrenia [3]. Anticipated discrimin-
ation by employers also forms a barrier to seeking mental
health care; this obstacle was reported more frequently than
any other in a recent study [4].
Given these high frequencies of experienced and antici-
pated discrimination among people with mental health pro-
blems, many choose not to disclose their condition prior to
being offered a job. This contrasts with employers’ reported
preferences that they do so, for example 77% in a UK sam-
ple surveyed in 2009 [5]. However, with the introduction of
the Equality Act 2010 it is now unlawful for employers in
Britain to enquire about an applicant’s disability or health,
until that person has either been offered a job or been
included in a pool of candidates to be offered a job when a
suitable position arises. Nothing in the Act prevents
employers asking health related questions once recruitment
decisions have been taken. This restriction is qualified by
several exclusions and is only enforceable by the Equality
and Human Rights Commission. However, its breach con-
stitutes evidence of disability discrimination.
In some circumstances disclosure may be obligatory. For
example, if a job environment is such that one’s disability
could present a risk to one’s health and safety or that of col-
leagues [6]. However, in most cases the Act does not obli-
gate disclosure of a mental illness prior to employment, so
it is up to the job candidate to decide whether to do so.
There are two important legal considerations [7]. First, a
claim for direct discrimination or discrimination arising
from disability can only be made where the employer knew
or ought to have known that the person was disabled.
Second, no duty arises to provide ‘reasonable adjustments’
if the employer does not know or could not reasonably be
expected to know that a person has a disability. There are
also many other considerations. Will colleaguesmisinterpret symptoms of mental illness [8] e.g. as sub-
stance misuse if one does not disclose? Will they gossip [9],
ignore them [8] or interpret every expression of emotion as
a symptom if they do? How much should one say, when
and to whom? Disclosure of mental illness in the employ-
ment context is therefore a personal, multilayered and po-
tentially difficult decision.
A decision aid (DA) is an educational intervention
designed to help an individual make a specific and deliber-
ate choice between two or more options. They are com-
monly used in medical decision-making when individuals
need to choose between treatment or screening options
[10]. A systematic review of 17 randomised trials of DAs
found that, compared with controls, DAs produced higher
knowledge, more active participation in decision making
and lower levels of decisional conflict [11,12].
This suggests that a DA may be a useful intervention
to increase knowledge about disclosure, reduce decisio-
nal conflict or increase active participation in this em-
ployment decision making.
We have recently developed a DA to assist people
with mental health problems consider disclosure in
the employment context (Conceal Or ReveAL, or
CORAL). In a non-randomised pilot study [13], the
CORAL DA demonstrated preliminary evidence of ac-
ceptability, feasibility and effectiveness in a group of
15 service users. We now wish to determine through
a randomised controlled trial whether using the
CORAL DA changes the user’s behaviour with respect
to seeking or retaining employment in ways that re-
sult in higher levels of employment and greater use
of workplace accommodations. These outcomes re-
quire larger sample sizes and a longer follow up
period than are justifiable at this point. To determine
whether such a trial is justifiable and feasible and to
optimise its design, our next step is to conduct a
proof of concept RCT.
Methods
Design
The CORAL trial is an individual-level single-blind RCT
of the CORAL decision aid compared with a treatment
as usual control for people receiving primary (Improving
Access to Psychological Therapies (IAPT)) or secondary
mental health care services in south east London. The
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for: regulatory approvals, recruitment; provision of the
intervention; follow-up assessments; qualitative explor-
ation of use of the DA; and data analysis, using intention
to treat methods. Recruitment to the trial began in July
2011 and is due for completion in June 2012. Follow-up
assessments began in October 2011 and will be com-
pleted by September 2012.
Setting
The settings are in London at locations where vocational
advisers employed or contracted by an NHS Foundation
Trust work with clients from the Trust and from IAPT.
Participants
Eligible service users will (i) be on the caseload of a spe-
cialist employment adviser working with people with
mental illness; (ii) have been referred to the adviser ei-
ther from the primary care based mental health service
Improving Access to Psychological Therapies (IAPT) or
secondary mental health care service; (iii) be aged
18 years or older; (iv) be currently seeking either paid or
voluntary employment or interested in seeking paid or
voluntary employment (v) have a Decisional Conflict
Scale score of 37.5 or greater (showing at least moderate
decisional conflict) and a Stage of Decision Scale score
of 1–5 (showing the decision has not yet been reached);
and (vi) give written, informed consent. We will exclude
service users who have insufficient literacy in English to
use the DA or who lack capacity to provide informed
consent. Figure 1 shows the CONSORT flow chart for
participants.
Intervention
A researcher will meet with each participant in the inter-
vention group and give them the DA to read and
complete.
The DA has been designed for use independent from
or as an adjunct to a clinical encounter [14]. It includes
six sections [1]: the pros and cons of disclosure [2]; per-
sonal disclosure needs [3]. personal disclosure values [4];
when to tell [5]; whom to tell [6]; making a decision,
which summarises the previous sections and asks the
participant to reflect on responses and make a decision
regarding when, what and to whom to disclose. The
researcher’s main role will be to record the time taken to
read and complete the DA and answer any questions or
clarify areas of confusion which arise. If the participant
has difficulty in understanding the DA then it will be
explained that part of the purpose of the study is to test
how easy it is for people to complete the DA and they
should use their best guess to answer the questions in it.
They will be reminded that there is a chance to discuss
any areas which caused confusion at a later stage of theinterview. If the participant is not satisfied with this ex-
planation then a choice of what the statement could
mean will be given. If this is not sufficient then a more
prescriptive set of instructions will be provided, with the
researcher guiding the participant through the DA as an
interview if necessary. Following this meeting, the par-
ticipant will be given their DA to keep and continue to
receive standard support from the vocational advisers, as
per the control condition.
Control
We have chosen to use a treatment as usual (TAU) con-
trol condition, as this provides a fair comparison with
routine practice by vocational advisers, and will answer
the question of whether use of the DA in addition to
current standard practice is superior to standard practice
alone. Employment advisers often discuss disclosure
needs with those clients seeking competitive employ-
ment, so that TAU will in many cases include an un-
structured discussion of some of the content covered by
the DA. Some vocational advisers using the supported
employment model encourage disclosure as part of the
process of obtaining work. However, advisers do not
routinely provide information about discrimination fol-
lowing disclosure and employees’ rights; instead they do
so in response to questions from a client. More broadly,
TAU consists of an initial assessment of work history,
qualifications, employment and career goals and clinical
information. Advisers then assist with augmenting job
seeking skills, finding training courses and voluntary pla-
cements and providing follow up to those in work. Sup-
port for people in work includes helping with requests
for workplace adjustments when the need for these
arises.
Objectives
The aims are to determine whether a full scale RCT
of the CORAL decision aid tool is justifiable and
feasible and to optimise its design [15,16]. Specific
objectives are to (i) establish parameters of a future
trial, by examining the effect of the DA on decisional
conflict regarding disclosure both immediately and at
3 months post first use and determining the optimal
primary outcome for a full scale trial from a range of
employment related measures; (ii) optimise the evalu-
ation, by testing study procedures, including: the sam-
ple that can be recruited and retained using the
inclusion and exclusion criteria; the resource implica-
tions in terms of full time equivalent needed for re-
search assistants to recruit sufficient numbers and
carry out the study procedures in the time available;
whether the batch of measures is acceptable vs. leads
to too much respondent burden; the use of a ques-
tionnaire on employment and disclosure related
Screened for eligibility N=
Excluded:
Ineligible N=
Declined to participate N=
Baseline interview N=
Randomised N=
Allocated to decision aid 
N=
Allocated to treatment as 
usual N=
Lost to follow up N= Lost to follow up N=
Analysed N= Analysed N=
Figure 1 Consort flow chart of CORAL trial design.
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vidual level randomisation, including the methods for
avoiding and measuring contamination; recruitment
and retention methods for service users and voca-
tional counsellors; the choice of measures for a full
scale trial based on results of qualitative interviews
with participants; (iii) optimise the intervention, by
collecting feedback on the DA form a larger sample
than was used in the previous pilot.
Hypotheses
While we shall conduct hypothesis testing this is not
the main objective of the study, as this is the purpose
of the future large scale trial. The reporting of this
study will not therefore emphasize the results of hy-
pothesis testing over the reporting of whether the
objectives were met [17]. Our hypotheses are derived
from the conceptual model in Figure 2 and fall intothree groups. Regarding the effect of the intervention,
we expect that, regardless of what the disclosure deci-
sion is, having a lower level of decisional conflict and
being at a later stage of decision will allow the par-
ticipant to take action regarding seeking work, result-
ing in a greater level of empowerment and a
reduction in behavioural withdrawal. Thus, compared
to the control group, those in the intervention group
will show at 3 months [1]: lower decisional conflict
regarding disclosure [2]; a later stage of decision mak-
ing regarding disclosure [3]; higher frequencies of
work related actions [4]; a higher level of empower-
ment [5] lower frequencies of withdrawal as a re-
sponse to stigma (in any context rather than just
employment). The model shown in Figure 2 will be
investigated using process evaluation and qualitative
data collection to identify the most robust associa-
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Figure 2 Mechanisms of DA intervention.
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sequent full scale RCT.
The DA is not designed either to cause an increase or
decrease in rates of disclosure to an actual or potential
employer but may have either effect. It may increase dis-
closure through increasing knowledge about being able
to request workplace adjustments. On the other hand,
knowing that there is a choice that can be made regard-
ing disclosure may make some people feel more
confident about not disclosing. We will therefore study
the relationship between use of the DA and subsequent
disclosure and use qualitative methods to explore any
apparent effect or lack thereof.
Primary outcome measures
Decisional conflict
The decisional conflict scale measures personal percep-
tions of: uncertainty in choosing between options; modi-
fiable factors contributing to uncertainty including
feeling uninformed, lack of clarity about personal values
and feeling unsupported in decision making; and effect-
ive decision making such as feeling the choice is
informed, values-based, likely to be implemented and
expressing satisfaction with the choice. The 16 item ver-
sion of the scale is the most commonly used [18]. A total
score and 5 sub-scores (uncertainty; informed; valuesclarity; support and effective decision) are generated.
Scores exceeding 37.5/100 are associated with decisional
delay or feeling unsure about implementation.
Stage of decision making
The stage of decision making scale measures the indivi-
dual’s readiness to engage in decision making [19]. It
consists of 1 item with 6 response options anchored at 1
(haven’t started to think about the choices) and 6 (have
already made a decision and am unlikely to change my
mind).
Employment related outcomes
We will administer a questionnaire to assess the occur-
rence and frequency of employment related activity and
disclosures made to employers. The baseline interviews
will be used to pilot this questionnaire. Its content will
cover the previous 3 months regarding: appointments
made and kept with the vocational counsellor; applica-
tions submitted; interviews attended; jobs offered and
accepted; verbal disclosure and its timing e.g. at inter-
view, post offer, after starting employment; written dis-
closure and its timing e.g. on application forms or
occupational health forms; requests for workplace
adjustments and the outcome of such requests; job loss
and reason for loss; other employment related activity
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employment and volunteering; and income or job title.
We will measure employment rates pre- and post-
intervention in each group. We will ask about income
from employment; if people are reluctant to disclose this
we will assume salary levels based on the job titles and
these salary levels will be used to reflect productivity
gains. The eight item short version of Work Limitations
Questionnaire [20] will also be included for participants
to self-assess work performance and these data will be
used to make estimates of productivity costs through
work limitations whilst at work.
Secondary outcome measures
Empowerment
The Boston University Empowerment Scale (BUES) 17-
item version consisting of the self-esteem-self-efficacy
and power-powerlessness subscales of the original 28
item scale used in a recent validation study [21].
Withdrawal
We shall use the 9 item withdrawal scale of the Stigma
Coping Orientation scales [22].
Predictors of intention to disclose: behaviour beliefs
Experienced discrimination
The Discrimination and Stigma Scale [3,13] is a 35 item,
interview-based scale. It contains a global scale and 4
subscales: 1) Unfair treatment; 2) Stopping self; 3) Over-
coming stigma and 4) Positive treatment. We will use
the 22 item Unfair treatment subscale only, which has
21 specific items and one item where other experiences
can be recorded.
Anticipated discrimination
The Questionnaire on Anticipated Discrimination (QUAD)
(www.sapphire.iop.kcl.ac.uk) is a self-complete measure
with 14 items which address ‘areas of anticipated discrimin-
ation’. It asks participants to provide a rating of whether
they expect to be treated unfairly in various areas of life.
Self-stigma
The Internalised Stigma of Mental Illness Scale (ISMI) is
a 29-item measure that assesses mental health service
users’ experience of internalised stigma. It is composed
of 5 sub-scales: Alienation, Stereotype Endorsement,




The Perceived Devaluation and Discrimination Scale
(PDD) is a 12-item, uni-dimensional, scale which mea-
sures the extent to which a person believes that mostpeople will devalue or discriminate against someone
with a mental illness [23,24];.
Control beliefs
Empowerment
The 17 item BUES will be used as above.
Coping orientation
Link et al. devised 5 short coping scales with a total of
20 items (the Stigma Coping Orientation Scales) to as-
sess various approaches to coping with the stigma
associated with mental illness. Five different coping
orientations are assessed: secrecy, withdrawal, educating,
challenging and distancing [22,25]. More general coping
orientation will be assessed using the revised Ways of
Coping Questionnaire (WCQ), a self-report instrument
which asks participants to think about a recent stressor
and rate the extent to which they used each of 24 beha-
viours to cope with it [26]. A revised factor structure for
the scale, as used with people with a diagnosis of schizo-
phrenia, has been proposed and will be used [27].
Qualitative data collection
Intervention group participants
Interviews will be conducted with up to 15 participants
after outcome measures have been administered. This
will explore the perceived impact of using the decision
aid with respect to (i) actual and intended disclosure;
(ii) job seeking behaviour and (iii) other behaviour e.g.
disclosure to others. We shall also enquire about experi-
ences over the follow up period which have modified or
reinforced intentions regarding disclosure or actual dis-
closure. Interviews will be recorded and transcribed.
Control group participants
Interviews will be conducted with up to 6 consenting
participants after outcome measures have been adminis-
tered. This will explore actual and intended disclosure in
relation to employment and others. While this was a
focus of previous qualitative work with service users
there have been subsequent changes both in relevant le-
gislation (the introduction of the Equality Act 2010) and
in the job market, which has contracted. Both of these
factors may have influenced disclosure intentions and
behaviours.
Vocational adviser interviews
Once participant follow up is completed we shall inter-
view a minimum of one adviser from each of the four
boroughs. The aim of these will be [1] to better describe
treatment as usual with respect to advising service users
about disclosure [2]; to identify whether any contamin-
ation has occurred, either due to specific use of the DA
or due to an increased focus on disclosure as a result of
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of relevant legislation; attitudes about what service users
should do with respect to disclosure; and practice with
respect to what advice is given, the extent to which the
advice is tailored to the client, and whether advice is
given routinely versus in response to client requests.
Transcripts of the qualitative interviews will be coded
using NVivo and thematic analysis will be used to iden-
tify participants’ perceptions of the impact of use of the
DA and the impact of subsequent experience on inten-
tions and behaviour regarding disclosure.
Sample size
The heuristic sample size for pilot studies is 30 per
group [16]. However, we have elected to use a larger
sample size so that we can test the effect of the DA with
respect to a meaningful reduction in decisional conflict.
The pre-post difference detected on the Decisional Con-
flict Scale in a preliminary study [13] was found to be
16.5 points in the intervention group, with a standard
deviation of 17.5. Estimating the effect of treatment as
usual (i.e. vocational advisor standard support) at 4
points, this gives a standardised effect size of 0.71.
Group sizes of 32 at the follow-up are needed to have
80% power to detect a difference of this size or greater
at the 5% significance level. Further to test our explora-
tory hypotheses and refine our conceptual model, in-
creasing from 64 (2×32) to 70 participants at follow up
will allow logistic regression analysis to study relation-
ships between baseline predictors and disclosure using 6
variables (plus the group variable), using the minimum
of 10 per variable. Since we anticipate some loss to fol-
low up at 3 months we shall aim to recruit 40 per group
i.e. a total of 80 participants. Qualitative interview sam-
ple sizes are based on our expectations for the number
of interviews required to cover a range of experiences
and to reach the point where no new themes are identi-
fied in the analysis.
Recruitment and randomisation
Ethics approval
The study has been approved by the National Research
Ethics Service Committee East of England – Essex.
Recruitment
Employment advisers attached to community mental
health teams and IAPT services will be asked to inform
people on their caseload about the study by giving them
a flyer summarising the main points of the study. With
service users’ permission the adviser will pass on contact
details of interested service users to the study research
worker. The worker will contact the service user to deter-
mine their eligibility, provide further study information to
those eligible, offer a period of time for consideration anddocument informed consent from those eligible and
wishing to enter the study.
Sequence generation
Block randomisation with randomly varying block sizes
will be used. We shall stratify by [1] referral source i.e.
primary vs. secondary mental health services, since these
groups are likely to differ with respect to severity of ill-
ness, and [2] by length of time out of work (less vs. more
than 12 months), as this affects chances of regaining
employment.
Allocation concealment
The sequence is concealed by the KCL Clinical Trials
Unit from the research team.
Implementation
All randomisation will be undertaken via the independ-
ent Clinical Trials Unit (CTU) (which has been awarded
full CTU registration by UKCRC) using an online ran-
domisation system. They will not be provided with iden-
tifying information about service users. Participants will
be enrolled by research workers blind to allocation while
the CTU will inform only the researchers carrying out
the intervention of allocation.
Blinding
The blinded research workers are located in a separate
office to those who are non-blind. It is not possible to
keep participants blind to the intervention. To ensure
the intervention occurs in as close a manner as possible
to that in routine practice while minimising contamin-
ation, intervention group participants will be allowed to
discuss the DA with vocational advisers but will be asked
not to give them a copy. This means that vocational
advisers cannot be blinded and therefore only the re-
search team will be blind. At follow-up assessment, par-
ticipants will be asked not to reveal their allocation
status, and at the end of the interview the rater will rec-
ord their guess about the service user’s allocation status.
This will allow researcher blindness to be estimated.
Analysis plan
The principal analysis of effectiveness will compare the
primary and secondary outcome measures at 3 months.
Changes in Decisional Conflict Scale scores are not
prone to cut-off limits and are expected to be normally
distributed. For both this and other normally distributed
continuous outcome measures, an independent two
sample t-test will be used to compare the change in
effects (T1-T0) for the two groups (control and interven-
tion). When continuous variables are predicted to be
skewed (e.g. number of disclosures made), these can be
tested using a two-sample Wilcoxon rank-sum test. The
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the two groups (control and intervention) can be com-
pared. While items such as job offers and disclosure will
be too infrequent to provide reliable comparisons, others
such as appointments kept with the vocational adviser
and submitted applications will be used as proxy mea-
sures for future employment outcomes. We will use con-
fidence intervals for the effect sizes for these
employment related activities to judge whether a full
scale trial is indicated.
Attendance and dropout rates can be compared in
terms of their baseline characteristics to see whether
there are any obvious differences between retained and
dropout participants. Adjustments to these analyses will
be made to compensate for multiple testing. To study
factors predicted by our model (see Figure 2) to be asso-
ciated with disclosure we will use logistic regression.
Each instrument will be studied to see whether it per-
forms well enough for inclusion in a future trial. A cor-
relation matrix will be formed from the items to
calculate internal consistency and reliability, and to as-
sess the appropriateness of forming composite or sum-
mary scores for previously defined sub-scales. Along
with the histograms of each subscale, the data allow as-
sessment of the appropriateness (particularly ceiling and
floor effects) of the measures. Variables that perform
well (and that appear not to be measuring the same
thing) will be included in the logistic regression model,
while adjusting for gender and diagnosis as these have
been found to be associated with disclosure in other
studies [28,29].
Discussion
This study will not include consideration of the cost-
effectiveness of the DA for two reasons. First, the meth-
ods for data collection for service and societal costs we
would use in a full scale trial have been well tested. Sec-
ond, since the current trial cannot include hypothesis
testing we are also unable to determine cost effective-
ness. We will however identify any extra resources e.g.
employment advisor time required to implement the
intervention and attach costs to these. Developmental
costs of the intervention could be included but appor-
tioned over a large number of people these would be
minimal.
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